论文信息 - KESTREL and KITE: 52-week results from two Phase III pivotal trials of brolucizumab for diabetic macular edema - 字舞流文

KESTREL and KITE: 52-week results from two Phase III pivotal trials of brolucizumab for diabetic macular edema

N. Ngah | E. Souied | G. Liew | R. Tadayoni | S. Wolf | J. Barranco | F. Bandello | J. Garweg | N. Guérard | Lidija Kovačič | David M. Brown | Vishali Gupta | D. Dhoot | J. Figueira | E. Bouillaud | R. Tuli | Ying Wang | Lixin Wang | A. Emanuelli